Search research articles
Contact Us
Filters
Showing results (121-130 of 224) with videos related to
Page
of 23
Sort By:
Cancer Cell
|
October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors
Lydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 27, 2011
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF
Gabi Tarcic, Roi Avraham, Gur Pines, et al.
Molecular Cell
|
May 21, 2011
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals
Yaara Zwang, Aldema Sas-Chen, Yotam Drier, et al.
Nature Communications
|
May 10, 2020
p85β regulates autophagic degradation of AXL to activate oncogenic signaling
Ling Rao, Victor C Y Mak, Yuan Zhou, et al.
Nature Methods
|
September 17, 2013
TCPA: a resource for cancer functional proteomics data
Jun Li, Yiling Lu, Rehan Akbani, et al.
Plos One
|
October 7, 2020
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA
Noriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2015
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer
Karina E Hew, Philip C Miller, Dorraya El-Ashry, et al.
Nature Genetics
|
February 27, 2007
A module of negative feedback regulators defines growth factor signaling
Ido Amit, Ami Citri, Tal Shay, et al.
Science Signaling
|
September 13, 2012
Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis
Daisuke Hoshino, Jerome Jourquin, Shane Weller Emmons, et al.
EMBO Molecular Medicine
|
December 17, 2011
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer
Yun-Yong Park, Kyounghyun Kim, Sang-Bae Kim, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 224) with videos related to
Sort By:
Page
of 23
Cancer Cell
|
October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors
Lydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 27, 2011
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF
Gabi Tarcic, Roi Avraham, Gur Pines, et al.
Molecular Cell
|
May 21, 2011
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals
Yaara Zwang, Aldema Sas-Chen, Yotam Drier, et al.
Nature Communications
|
May 10, 2020
p85β regulates autophagic degradation of AXL to activate oncogenic signaling
Ling Rao, Victor C Y Mak, Yuan Zhou, et al.
Nature Methods
|
September 17, 2013
TCPA: a resource for cancer functional proteomics data
Jun Li, Yiling Lu, Rehan Akbani, et al.
Plos One
|
October 7, 2020
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA
Noriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2015
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer
Karina E Hew, Philip C Miller, Dorraya El-Ashry, et al.
Nature Genetics
|
February 27, 2007
A module of negative feedback regulators defines growth factor signaling
Ido Amit, Ami Citri, Tal Shay, et al.
Science Signaling
|
September 13, 2012
Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis
Daisuke Hoshino, Jerome Jourquin, Shane Weller Emmons, et al.
EMBO Molecular Medicine
|
December 17, 2011
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer
Yun-Yong Park, Kyounghyun Kim, Sang-Bae Kim, et al.
Page
of 23